Kate Peacock
Overview
Explore the profile of Kate Peacock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eberly A, Valencia A, Peacock K, McDonald D, Hink T, Samuels C, et al.
Antimicrob Steward Healthc Epidemiol
. 2025 Jan;
5(1):e10.
PMID: 39839357
Objective: To compare the recovery of yeast from hospital surfaces from two different collection methods: Eswab moistened with molecular water, and premoistened stick-mounted sponge. Design: Comparison of collection methods for...
2.
Tiwary S, ONeil C, Peacock K, Cass C, Amor M, Wallace M, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Oct;
4(1):e184.
PMID: 39450093
Objective: To measure SARS-CoV-2 anti-nucleocapsid (anti-N) antibody seropositivity among healthcare personnel (HCP) without a history of COVID-19 and to identify HCP characteristics associated with seropositivity. Design: Prospective cohort study from...
3.
Bosserman R, Farnsworth C, ONeil C, Cass C, Park D, Ballman C, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 Aug;
3(1):e133.
PMID: 37592963
Objective: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify...
4.
Farnsworth C, ONeil C, Dalton C, McDonald D, Vogt L, Hock K, et al.
J Appl Lab Med
. 2023 Jul;
8(5):871-886.
PMID: 37478837
Background: SARS-CoV-2 vaccines are effective at reducing symptomatic and asymptomatic COVID-19. Limited studies have compared symptoms, threshold cycle (Ct) values from reverse transcription (RT)-PCR testing, and serological testing results between...
5.
Kwon J, Budge P, ONeil C, Peacock K, Aagaard E, Fraser V, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e123.
PMID: 36505949
Objective: To identify characteristics associated with positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) tests in healthcare personnel. Design: Retrospective cohort study. Setting: A multihospital healthcare...
6.
Bosserman R, Farnsworth C, ONeil C, Cass C, Park D, Ballman C, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e93.
PMID: 36483363
In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were...
7.
Gandra S, Li T, Reske K, Peacock K, Hock K, Bommarito S, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e125.
PMID: 36483341
In this prospective, longitudinal study, we examined the risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among a cohort of chronic hemodialysis (HD) patients and healthcare personnel...
8.
Randall D, Peacock K, Nickel K, Olsen M, Kazmers N
J Hand Surg Am
. 2022 Dec;
47(12):1137-1145.
PMID: 36471499
Purpose: Our primary purpose was to quantify the proportion of minor hand surgeries performed in the procedure room (PR) setting in a population-based cohort. Given the increase in the literature...
9.
Sung A, Bailey A, Stewart H, McDonald D, Wallace M, Peacock K, et al.
Front Cell Infect Microbiol
. 2022 Feb;
12:804175.
PMID: 35186791
Immunocompromised adults can have prolonged acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive RT-PCR results, long after the initial diagnosis of coronavirus disease 2019 (COVID-19). This study aimed to determine if...
10.
Olsen M, Greenberg J, Peacock K, Nickel K, Fraser V, Warren D
J Antimicrob Chemother
. 2022 Jan;
77(4):1178-1184.
PMID: 35040936
Objectives: To determine the prevalence and factors associated with post-discharge prophylactic antibiotic use after spinal fusion and whether use was associated with decreased risk of surgical site infection (SSI). Methods:...